Evaluation of biosafety and intracellular uptake of Cremophor EL free paclitaxel elastic liposomal formulation

By Utreja Puneet   Jain Subheet   Tiwary A. K.  

Drug Delivery, Vol. 19, Iss. 1, 2012-01 ,pp. : 11-20

Informa Healthcare

Access to resources Recommend Favorite

Paclitaxel in a novel formulation containing less Cremophor EL as first-line therapy for advanced breast cancer: A phase II trial

By Ta-Chung Chao   Zyting Chu   Ling-Ming Tseng   Tzeon-Jye Chiou   Ruey-Kuen Hsieh   Wei-Shu Wang   Chueh-Chuan Yen   Muh-Hwa Yang   Liang-Tsai Hsiao   Jin-Hwang Liu   Po-Min Chen  

Investigational New Drugs, Vol. 23, Iss. 2, 2005-01 ,pp. : 171-177

Springer Publishing Company

Access to resources Recommend Favorite

A HPLC validated assay of paclitaxel's related impurities in pharmaceutical forms containing Cremophor ( R) EL

By Ciutaru D.   Badea I.   Lazar L.   Nicolescu D.   Tudose A.  

Journal of Pharmaceutical and Biomedical Analysis, Vol. 34, Iss. 3, 2004-02 ,pp. : 493-499

Elsevier

Access to resources Recommend Favorite

Modulation of radiation-induced organs toxicity by cremophor-el in experimental animals

By Ramadan L.A.   Shouman S.A.   Sayed-Ahmed M.M.   El-Habit O.H.  

Pharmacological Research, Vol. 43, Iss. 2, 2001-02 ,pp. : 185-191

Academic Press

Access to resources Recommend Favorite

Increasing the Proportional Content of Surfactant (Cremophor EL) Relative to Lipid in Self-emulsifying Lipid-based Formulations of Danazol Reduces Oral Bioavailability in Beagle Dogs

By Cuiné Jean   Charman William   Pouton Colin   Edwards Glenn   Porter Christopher  

Pharmaceutical Research, Vol. 24, Iss. 4, 2007-04 ,pp. : 748-757

Springer Publishing Company

Access to resources Recommend Favorite